EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain—Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam

Krisztina Kelemen iD, Károly Orbán-Kis iD, Ádám Szentes, Zsolt András Nagy, Hanga Kelemen iD, Anna Fehér, László-István Bába iD, Zsolt Gáll iD, Eszter Horváth, István Katona, Szabolcs Szatmári iD, József Attila Szász iD und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Krisztina Kelemen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Levetiracetam, Pyrrolidinones, Neurons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcium-binding proteins (CaBPs) are known to modulate neuronal excitability and calcium signaling, and they may play a role in the imbalances of excitation and inhibition of temporal lobe epilepsy (TLE). While parvalbumin and calretinin are well-characterized CaBPs, N-Terminal EF-Hand Calcium-Binding Protein 1 (NECAB1) remains understudied in epilepsy, despite its association with neurodegenerative conditions. In this study, we used fluorescent immunolabeling to determine the distribution of NECAB1, as well as its co-expression with parvalbumin and calretinin, in brain regions associated with the epileptic circuitry using a kainic acid-induced TLE model. Additionally, we examined the impact of levetiracetam and brivaracetam on NECAB1 expression. In our study, NECAB1-positive cells were prominently localized to the paraventricular nucleus of the thalamus (PVT), endopiriform nucleus (EPN), and amygdala in healthy brain regions involved in epileptic circuitry. A NECAB1–calretinin co-expressing subpopulation was detected in the amygdala, PVT, and hippocampus but was nearly absent in the EPN. In chronic epilepsy, NECAB1 expression was significantly upregulated in the PVT and bilaterally in the amygdala. These findings suggest that NECAB1 upregulation may compensate for epileptic hyperexcitability, potentially contributing to circuit remodeling via thalamocortical regulation and interneuron diversity. Levetiracetam and brivaracetam treatments partially reduced the NECAB1 density increase in TLE, indicating a modulatory effect on NECAB1 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeLevetiracetamPyrrolidinonesNeuronsAnticonvulsantsBrainCalcium-Binding ProteinsAnimalsMaleDisease Models, AnimalRatsCalbindin 2

Stichwörter der Autor:innen

NECAB1SV2A associated antiseizure treatmentamygdalabrivaracetamcalcium-binding proteinsendopiriform nucleushippocampuslevetiracetamparaventricular nucleus of the thalamustemporal lobe epilepsy

Substanzen

LevetiracetambrivaracetamPyrrolidinonesAnticonvulsantsCalcium-Binding ProteinsCalbindin 2

Autor:innen und Institutionen

  • Department of Physiology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania.
  • Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania.
  • Molecular Neurobiology Research Group, HUN-REN Institute of Experimental Medicine, Szigony st 43, H-1083 Budapest, Hungary.
  • Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania.
  • Translational Behavioural Neuroscience Research Group, HUN-REN Institute of Experimental Medicine, Szigony st 43, H-1083 Budapest, Hungary.
  • János Szentágothai Neurosciences Division, Doctoral College, Semmelweis University, Ulloi st 26, H-1085 Budapest, Hungary.

ORCID-Profile: Krisztina Kelemen, Károly Orbán-Kis, Hanga Kelemen, László-István Bába, Zsolt Gáll, Szabolcs Szatmári, József Attila Szász, Tibor Szilágyi

Zitieren

APA

Kelemen, K., Orbán-Kis, K., Szentes, Á., Nagy, Z. A., Kelemen, H., Fehér, A., Bába, L. I., Gáll, Z., Horváth, E., Katona, I., Szatmári, S., Szász, J. A., & Szilágyi, T. (2025). Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain—Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104906

Vancouver

Kelemen K, Orbán-Kis K, Szentes Á, Nagy ZA, Kelemen H, Fehér A, et al. Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain—Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104906

BibTeX
@article{Kelemen2025,
  author = {Kelemen, Krisztina and Orbán-Kis, Károly and Szentes, Ádám and Nagy, Zsolt András and Kelemen, Hanga and Fehér, Anna and Bába, László-István and Gáll, Zsolt and Horváth, Eszter and Katona, István and Szatmári, Szabolcs and Szász, József Attila and Szilágyi, Tibor},
  title = {Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain—Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104906}
}
Kostenlos starten →